CiPAevaluation はまだ何も投稿していません
about
In evaluation of cardiac toxicity of drug candidates, many drugs with effects on hERG and QTc prolongation but little actual Torsades de pointes (TdP) risk are deprioritized or excluded from further development or, if approved, see their clinical use limited by inappropriate warnings in product labeling.
Here at Creative Bioarray, we provide our clients with a comprehensive pack of CiPA evaluation service.
